PTEN and prostate cancer: PTEN loss in the murine prostatic epithelial in the PB-Cre+PtenloxP/loxP (Pten-null) mouse model mimics both molecular and pathological features associated with human prostate cancers, including upregulated PI3K pathway, invasive adenocarcinoma, as well as resistant to ADT15–17.